![]() Taysha Gene Therapies Taysha Gene Therapies is a biotechnology company that develops treatments to eradicate monogenic diseases of the central nervous system (CNS). | ![]() Passage Bio Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases. | Oscine Therapeutics Oscine Therapeutics is a company developing a cell therapy platform for the treatment of CNS diseases. | ||
Founding Date | Founding Date 2020 | Founding Date 2018 | Founding Date 2017 | Founding Date N/A |
Type | Type Public | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Dallas, US HQ | Locations Philadelphia, US HQ | Locations Alachua, US HQ Alachua, US | Locations Rochester, US HQ |
Employees | Employees N/A | Employees 20 | Employees 47 | Employees N/A |
Valuation ($) | Valuation ($) 148.1 m | Valuation ($) 128.6 m | Valuation ($) N/A | Valuation ($) N/A |
Twitter followers | Twitter followers 405 | Twitter followers 587 | Twitter followers 119 | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 10 | Number of tweets (last 30 days) 5 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 2 | Average likes per tweet (last 30 days) 1.8 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 90% | Percentage of tweets with engagement (last 30 days) 60% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 410427 | Alexa Website Rank 317659 | Alexa Website Rank 595798 | Alexa Website Rank N/A |
Employee Rating | Employee Rating 2.5 | Employee Rating 5 | Employee Rating 4.8 | Employee Rating N/A |
Financial | ||||
Net income | Net income ($60m) (FY, 2020) | Net income ($112.2m) (FY, 2020) | Net income N/A | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 125m | Total funding raised $ 225.5m | Total funding raised $ 30m | Total funding raised N/A |
Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases.
View companyLacerta Therapeutics is a clinical stage gene therapy company.
View companyOscine Therapeutics is a company developing a cell therapy platform for the treatment of CNS diseases.
View company